Global Sustained Release Injectables Sales Market Report 2021

1 Sustained Release Injectables Market Overview

• 1.1 Sustained Release Injectables Product Scope
• 1.2 Sustained Release Injectables Segment by Type
  • 1.2.1 Global Sustained Release Injectables Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Naltrexone
  • 1.2.3 Exenatide
  • 1.2.4 Estradiol
  • 1.2.5 Other
• 1.3 Sustained Release Injectables Segment by Application
  • 1.3.1 Global Sustained Release Injectables Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Diabetes
  • 1.3.3 Leukemia
  • 1.3.4 Acromegaly
  • 1.3.5 Other
• 1.4 Sustained Release Injectables Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Sustained Release Injectables Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Sustained Release Injectables Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Sustained Release Injectables Price Trends (2016-2027)

2 Sustained Release Injectables Estimates and Forecasts by Region

• 2.1 Global Sustained Release Injectables Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Sustained Release Injectables Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Sustained Release Injectables Revenue Market Share by Region (2016-2021)
• 2.3 Global Sustained Release Injectables Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Sustained Release Injectables Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Sustained Release Injectables Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Sustained Release Injectables Estimates and Projections (2016-2027)
  • 2.4.2 Europe Sustained Release Injectables Estimates and Projections (2016-2027)
  • 2.4.3 China Sustained Release Injectables Estimates and Projections (2016-2027)
  • 2.4.4 Japan Sustained Release Injectables Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Sustained Release Injectables Estimates and Projections (2016-2027)
  • 2.4.6 India Sustained Release Injectables Estimates and Projections (2016-2027)

3 Global Sustained Release Injectables Competition Landscape by Players

• 3.1 Global Top Sustained Release Injectables Players by Sales (2016-2021)
• 3.2 Global Top Sustained Release Injectables Players by Revenue (2016-2021)
• 3.3 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2020)
• 3.4 Global Sustained Release Injectables Average Price by Company (2016-2021)
• 3.5 Manufacturers Sustained Release Injectables Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Sustained Release Injectables Market Size by Type

• 4.1 Global Sustained Release Injectables Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Sustained Release Injectables Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Sustained Release Injectables Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Sustained Release Injectables Price by Type (2016-2021)
• 4.2 Global Sustained Release Injectables Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Sustained Release Injectables Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Sustained Release Injectables Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Sustained Release Injectables Price Forecast by Type (2022-2027)

5 Global Sustained Release Injectables Market Size by Application

• 5.1 Global Sustained Release Injectables Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Sustained Release Injectables Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Sustained Release Injectables Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Sustained Release Injectables Price by Application (2016-2021)
• 5.2 Global Sustained Release Injectables Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Sustained Release Injectables Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Sustained Release Injectables Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Sustained Release Injectables Price Forecast by Application (2022-2027)

6 North America Sustained Release Injectables Market Facts & Figures

• 6.1 North America Sustained Release Injectables Sales by Company
  • 6.1.1 North America Sustained Release Injectables Sales by Company (2016-2021)
  • 6.1.2 North America Sustained Release Injectables Revenue by Company (2016-2021)
• 6.2 North America Sustained Release Injectables Sales Breakdown by Type
  • 6.2.1 North America Sustained Release Injectables Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Sustained Release Injectables Sales Breakdown by Type (2022-2027)
• 6.3 North America Sustained Release Injectables Sales Breakdown by Application
  • 6.3.1 North America Sustained Release Injectables Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Sustained Release Injectables Sales Breakdown by Application (2022-2027)

7 Europe Sustained Release Injectables Market Facts & Figures

• 7.1 Europe Sustained Release Injectables Sales by Company
  • 7.1.1 Europe Sustained Release Injectables Sales by Company (2016-2021)
  • 7.1.2 Europe Sustained Release Injectables Revenue by Company (2016-2021)
• 7.2 Europe Sustained Release Injectables Sales Breakdown by Type
  • 7.2.1 Europe Sustained Release Injectables Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Sustained Release Injectables Sales Breakdown by Type (2022-2027)
• 7.3 Europe Sustained Release Injectables Sales Breakdown by Application
  • 7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Sustained Release Injectables Market Facts & Figures

• 8.1 China Sustained Release Injectables Sales by Company
  • 8.1.1 China Sustained Release Injectables Sales by Company (2016-2021)
  • 8.1.2 China Sustained Release Injectables Revenue by Company (2016-2021)
• 8.2 China Sustained Release Injectables Sales Breakdown by Type
  • 8.2.1 China Sustained Release Injectables Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Sustained Release Injectables Sales Breakdown by Type (2022-2027)
• 8.3 China Sustained Release Injectables Sales Breakdown by Application
  • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Sustained Release Injectables Market Facts & Figures

• 9.1 Japan Sustained Release Injectables Sales by Company
  • 9.1.1 Japan Sustained Release Injectables Sales by Company (2016-2021)
  • 9.1.2 Japan Sustained Release Injectables Revenue by Company (2016-2021)
• 9.2 Japan Sustained Release Injectables Sales Breakdown by Type
  • 9.2.1 Japan Sustained Release Injectables Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Sustained Release Injectables Sales Breakdown by Type (2022-2027)
• 9.3 Japan Sustained Release Injectables Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Sustained Release Injectables Market Facts & Figures

• 10.1 Southeast Asia Sustained Release Injectables Sales by Company
  • 10.1.1 Southeast Asia Sustained Release Injectables Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Sustained Release Injectables Revenue by Company (2016-2021)
• 10.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type
  • 10.2.1 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Sustained Release Injectables Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Sustained Release Injectables Market Facts & Figures

• 11.1 India Sustained Release Injectables Sales by Company
  • 11.1.1 India Sustained Release Injectables Sales by Company (2016-2021)
  • 11.1.2 India Sustained Release Injectables Revenue by Company (2016-2021)
• 11.2 India Sustained Release Injectables Sales Breakdown by Type
  • 11.2.1 India Sustained Release Injectables Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Sustained Release Injectables Sales Breakdown by Type (2022-2027)
• 11.3 India Sustained Release Injectables Sales Breakdown by Application
  • 11.3.1 India Sustained Release Injectables Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Sustained Release Injectables Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Sustained Release Injectables Business

• 12.1 AstraZeneca
  • 12.1.1 AstraZeneca Corporation Information
  • 12.1.2 AstraZeneca Business Overview
  • 12.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 AstraZeneca Sustained Release Injectables Products Offered
  • 12.1.5 AstraZeneca Recent Development
• 12.2 Eli Lilly
  • 12.2.1 Eli Lilly Corporation Information
  • 12.2.2 Eli Lilly Business Overview
  • 12.2.3 Eli Lilly Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Eli Lilly Sustained Release Injectables Products Offered
  • 12.2.5 Eli Lilly Recent Development
• 12.3 Sanofi
  • 12.3.1 Sanofi Corporation Information
  • 12.3.2 Sanofi Business Overview
  • 12.3.3 Sanofi Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Sanofi Sustained Release Injectables Products Offered
  • 12.3.5 Sanofi Recent Development
• 12.4 Roche
  • 12.4.1 Roche Corporation Information
  • 12.4.2 Roche Business Overview
  • 12.4.3 Roche Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Roche Sustained Release Injectables Products Offered
  • 12.4.5 Roche Recent Development
• 12.5 Novartis
  • 12.5.1 Novartis Corporation Information
  • 12.5.2 Novartis Business Overview
  • 12.5.3 Novartis Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Novartis Sustained Release Injectables Products Offered
  • 12.5.5 Novartis Recent Development
• 12.6 Aurobindo
  • 12.6.1 Aurobindo Corporation Information
  • 12.6.2 Aurobindo Business Overview
  • 12.6.3 Aurobindo Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Aurobindo Sustained Release Injectables Products Offered
  • 12.6.5 Aurobindo Recent Development
• 12.7 Avadel
  • 12.7.1 Avadel Corporation Information
  • 12.7.2 Avadel Business Overview
  • 12.7.3 Avadel Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Avadel Sustained Release Injectables Products Offered
  • 12.7.5 Avadel Recent Development
• 12.8 Biomarin
  • 12.8.1 Biomarin Corporation Information
  • 12.8.2 Biomarin Business Overview
  • 12.8.3 Biomarin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Biomarin Sustained Release Injectables Products Offered
  • 12.8.5 Biomarin Recent Development
• 12.9 Camurus
  • 12.9.1 Camurus Corporation Information
  • 12.9.2 Camurus Business Overview
  • 12.9.3 Camurus Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Camurus Sustained Release Injectables Products Offered
  • 12.9.5 Camurus Recent Development
• 12.10 Critical Pharmaceuticals
  • 12.10.1 Critical Pharmaceuticals Corporation Information
  • 12.10.2 Critical Pharmaceuticals Business Overview
  • 12.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Critical Pharmaceuticals Sustained Release Injectables Products Offered
  • 12.10.5 Critical Pharmaceuticals Recent Development
• 12.11 Alkermes
  • 12.11.1 Alkermes Corporation Information
  • 12.11.2 Alkermes Business Overview
  • 12.11.3 Alkermes Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Alkermes Sustained Release Injectables Products Offered
  • 12.11.5 Alkermes Recent Development
• 12.12 Amylin
  • 12.12.1 Amylin Corporation Information
  • 12.12.2 Amylin Business Overview
  • 12.12.3 Amylin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Amylin Sustained Release Injectables Products Offered
  • 12.12.5 Amylin Recent Development
• 12.13 Ascendis Pharma
  • 12.13.1 Ascendis Pharma Corporation Information
  • 12.13.2 Ascendis Pharma Business Overview
  • 12.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Ascendis Pharma Sustained Release Injectables Products Offered
  • 12.13.5 Ascendis Pharma Recent Development
• 12.14 Taiwan Liposome Company
  • 12.14.1 Taiwan Liposome Company Corporation Information
  • 12.14.2 Taiwan Liposome Company Business Overview
  • 12.14.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Taiwan Liposome Company Sustained Release Injectables Products Offered
  • 12.14.5 Taiwan Liposome Company Recent Development

13 Sustained Release Injectables Manufacturing Cost Analysis

• 13.1 Sustained Release Injectables Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Sustained Release Injectables
• 13.4 Sustained Release Injectables Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Sustained Release Injectables Distributors List
• 14.3 Sustained Release Injectables Customers

15 Market Dynamics

• 15.1 Sustained Release Injectables Market Trends
• 15.2 Sustained Release Injectables Drivers
• 15.3 Sustained Release Injectables Market Challenges
• 15.4 Sustained Release Injectables Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List